Published in Arthritis Res Ther on December 17, 2008
Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study. Arthritis Res Ther (2009) 1.39
Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol (2010) 1.04
Management of cardiovascular disease risk in chronic inflammatory disorders. Nat Rev Rheumatol (2009) 0.98
Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther (2010) 0.91
Metabolic syndrome in rheumatoid arthritis: case control study. BMC Musculoskelet Disord (2013) 0.89
Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion. Ther Adv Musculoskelet Dis (2013) 0.89
Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study. Medicine (Baltimore) (2015) 0.89
Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation. Clin Rheumatol (2010) 0.89
The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies. PLoS One (2013) 0.88
Metabolic syndrome in rheumatoid arthritis. Mediators Inflamm (2013) 0.87
Metabolic syndrome in rheumatoid arthritis. Maedica (Buchar) (2012) 0.82
Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial. BMJ Open (2014) 0.81
Is the frequency of metabolic syndrome higher in South Korean women with rheumatoid arthritis than in healthy subjects? Korean J Intern Med (2013) 0.81
Prevalence of metabolic syndrome in women with rheumatoid arthritis and effective factors. Int J Clin Exp Med (2014) 0.80
Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases. Clin Rheumatol (2014) 0.76
Cardiovascular disease risk scores in the current practice: which to use in rheumatoid arthritis? J Med Life (2015) 0.76
Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients. Arthritis Res Ther (2013) 0.76
Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps. Ther Adv Musculoskelet Dis (2016) 0.76
Asymptomatic atherosclerosis in egyptian rheumatoid arthritis patients and its relation to disease activity. Int J Rheumatol (2015) 0.75
Cardiovascular risk management in patients with inflammatory arthritis: what is good for the joint is good for the heart and vice versa! F1000 Med Rep (2010) 0.75
Evaluation of Anti-inflammatory Effects of Steroids and Arthritis-Related Biotherapies in an In Vitro Coculture Model with Immune Cells and Synoviocytes. Front Immunol (2016) 0.75
Risk of ischemic stroke in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis. Rheumatol Int (2014) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med (1998) 46.95
Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum (1995) 26.94
Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA (2002) 25.68
The metabolic syndrome--a new worldwide definition. Lancet (2005) 23.51
Length of life and cause of death in rheumatoid arthritis. N Engl J Med (1953) 7.62
The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med (1995) 5.83
Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol (1986) 5.82
Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabet Med (1999) 5.59
The emerging epidemic of obesity in developing countries. Int J Epidemiol (2005) 5.48
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet (2008) 4.70
The metabolic syndrome: more than the sum of its parts? Circulation (2003) 3.22
Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol (2006) 3.18
Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes (2003) 2.76
Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum (2002) 2.62
Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology (Oxford) (2003) 2.54
The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin (1949) 2.49
Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest (1994) 2.01
Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis (2003) 1.91
Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis (2007) 1.73
Glucocorticoids and insulin sensitivity in rheumatoid arthritis. J Rheumatol (2004) 1.62
Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology (Oxford) (2004) 1.59
Steroid myopathy. Clinical, histologic and cytologic observations. Johns Hopkins Med J (1968) 1.59
Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension (1999) 1.58
Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care (2004) 1.54
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study. Arthritis Res Ther (2006) 1.52
Leflunomide and hypertension. Ann Rheum Dis (2002) 1.50
Pharmacotherapy for asthma and chronic obstructive pulmonary disease. Current thinking, practices, and controversies. Arch Intern Med (1993) 1.46
Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis (2007) 1.46
Hypertension in rheumatoid arthritis. Rheumatology (Oxford) (2008) 1.36
Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Metabolism (1988) 1.35
Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol (2006) 1.30
Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia. Rheumatology (Oxford) (2007) 1.25
Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int (2004) 1.19
Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis (1991) 1.15
Steroid myopathy in connective tissue disease. Am J Med (1976) 1.15
Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis (2006) 1.15
Cardiology patient pages. Exercise and cardiovascular health. Circulation (2003) 1.15
Inflammation, the metabolic syndrome and cardiovascular risk. Int J Clin Pract Suppl (2003) 1.14
Inflammation and atherosclerosis in rheumatoid arthritis. Expert Rev Mol Med (2005) 1.13
Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. Rheumatology (Oxford) (2008) 1.12
Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease. J Clin Endocrinol Metab (1995) 1.11
Exercise acutely increases high density lipoprotein-cholesterol and lipoprotein lipase activity in trained and untrained men. Metabolism (1987) 1.09
Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. Arch Intern Med (1987) 1.07
Dyslipidemia and rheumatoid arthritis. Ann Rheum Dis (1997) 1.06
Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study. J Rheumatol (2007) 1.05
Use of oral corticosteroids and the risk of acute myocardial infarction. Atherosclerosis (2006) 1.02
Hyperlipidaemia in asthmatic patients receiving long-term steroid therapy. Br Med J (1973) 1.01
Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroids. Clin Transplant (2008) 1.01
Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids. Am J Med (1987) 1.01
Dyslipidaemia, hypercoagulability and the metabolic syndrome. Curr Vasc Pharmacol (2006) 0.99
The prevalence and management of hyperglycaemia in patients with rheumatoid arthritis on corticosteroid therapy. Scott Med J (2004) 0.97
Glucocorticoid use and serum lipid levels in US adults: the Third National Health and Nutrition Examination Survey. Arthritis Rheum (2005) 0.94
Impaired glucose handling in active rheumatoid arthritis: effects of corticosteroids and antirheumatic treatment. Metabolism (1987) 0.93
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3. Ann Rheum Dis (2005) 0.91
EMPIRE Rheumatism Council: multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis; results of three years' treatment. Ann Rheum Dis (1957) 0.90
Glucocorticoid use in rheumatoid arthritis: benefits, mechanisms, and risks. Clin Exp Rheumatol (2004) 0.89
Glucocorticoids in rheumatoid arthritis: effects on erosions and bone. Ann N Y Acad Sci (2002) 0.86
Adrenocortical steroid treatment of rheumatic diseases. Effects on lipid metabolism. Arch Intern Med (1973) 0.85
Glucocorticoid effect on insulin sensitivity: a time frame. J Endocrinol Invest (2008) 0.85
Glucocorticoids upregulate high-affinity, high-density lipoprotein binding sites in rat hepatocytes. Metabolism (1995) 0.83
Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men. Metabolism (1988) 0.83
Steroids and the metabolic syndrome. J Steroid Biochem Mol Biol (2008) 0.83
Is atherosclerosis in rheumatoid arthritis related to disease severity and extraarticular manifestations? Comment on the article by Chung et al. Arthritis Rheum (2006) 0.80
Serum Cholesterol in Rheumatic Diseases. Br Med J (1963) 0.78
Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des (2011) 4.16
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Rheumatology (Oxford) (2012) 3.56
Biomedical journal editing: elements of success. Croat Med J (2011) 3.06
Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol (2005) 2.28
Diversity, value and limitations of the journal impact factor and alternative metrics. Rheumatol Int (2011) 2.05
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int (2011) 1.59
Best peer reviewers and the quality of peer review in biomedical journals. Croat Med J (2012) 1.54
Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin. Circulation (2013) 1.53
Authorship problems in scholarly journals: considerations for authors, peer reviewers and editors. Rheumatol Int (2012) 1.52
Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis (2007) 1.46
Self-correction in biomedical publications and the scientific impact. Croat Med J (2014) 1.44
Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function. Mol Aspects Med (2002) 1.43
Conflicts of interest in biomedical publications: considerations for authors, peer reviewers, and editors. Croat Med J (2013) 1.40
Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study. Arthritis Res Ther (2009) 1.39
Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol (2013) 1.39
Open access: changing global science publishing. Croat Med J (2013) 1.38
Obesity in rheumatoid arthritis. Rheumatology (Oxford) (2010) 1.32
Upgrading instructions for authors of scholarly journals. Croat Med J (2014) 1.31
Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Arterioscler Thromb Vasc Biol (2009) 1.30
Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis. Eur J Cardiovasc Prev Rehabil (2009) 1.30
Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-α therapy. Rheumatol Int (2010) 1.28
Promoting transparent and accurate reporting of research studies in rheumatology: endorsement of reporting guidelines in rheumatology journals. Semin Arthritis Rheum (2013) 1.23
Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann Rheum Dis (2009) 1.22
The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J (2010) 1.21
Well-being in rheumatoid arthritis: the effects of disease duration and psychosocial factors. J Health Psychol (2005) 1.20
Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking. Atherosclerosis (2008) 1.19
Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology (Oxford) (2011) 1.16
Aberrant reactive oxygen and nitrogen species generation in rheumatoid arthritis (RA): causes and consequences for immune function, cell survival, and therapeutic intervention. Antioxid Redox Signal (2010) 1.13
Inflammation and atherosclerosis in rheumatoid arthritis. Expert Rev Mol Med (2005) 1.13
Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int (2011) 1.12
Multidisciplinary bibliographic databases. J Korean Med Sci (2013) 1.11
Inverted BMI rather than BMI is a better proxy for percentage of body fat. Ann Hum Biol (2011) 1.11
Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol (2010) 1.11
The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol (2010) 1.10
Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis. Arthritis Res Ther (2012) 1.09
Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clin Rheumatol (2008) 1.08
Oleate protects against palmitate-induced insulin resistance in L6 myotubes. Br J Nutr (2009) 1.06
The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species. Br J Pharmacol (2003) 1.06
The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin. Eur Heart J (2011) 1.05
Psychological well-being across 1 year with rheumatoid arthritis: coping resources as buffers of perceived stress. Br J Health Psychol (2007) 1.05
A novel silicon membrane-based biosensing platform using distributive sensing strategy and artificial neural networks for feature analysis. Biomed Microdevices (2012) 1.05
Urinary 8-oxo-2'-deoxyguanosine: redox regulation of DNA repair in vivo? Free Radic Biol Med (2002) 1.04
Proteomic analysis of a noninvasive human model of acute inflammation and its resolution: the twenty-one day gingivitis model. J Proteome Res (2010) 1.03
An aqueous extract of Fagonia cretica induces DNA damage, cell cycle arrest and apoptosis in breast cancer cells via FOXO3a and p53 expression. PLoS One (2012) 1.01
Individualised aerobic and resistance exercise training improves cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis. Ann Rheum Dis (2012) 1.01
Dietary habits are major determinants of the plasma antioxidant status in healthy elderly subjects. Br J Nutr (2005) 0.99
Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis. Endothelium (2008) 0.99
Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors. Curr Vasc Pharmacol (2010) 0.99
Inflammation, carotid intima-media thickness and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther (2008) 0.99
The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study. Arthritis Res Ther (2012) 0.99
The impact of inflammation on metabolomic profiles in patients with arthritis. Arthritis Rheum (2013) 0.97
The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther (2011) 0.96
An assessment of back pain and the prevalence of sacroiliitis in sarcoidosis. Chest (2005) 0.95
Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis. Ann Rheum Dis (2011) 0.95
Vascular function and inflammation in rheumatoid arthritis: the role of physical activity. Open Cardiovasc Med J (2010) 0.94
Association of the TRAF1/C5 locus with increased mortality, particularly from malignancy or sepsis, in patients with rheumatoid arthritis. Arthritis Rheum (2009) 0.94
Disease activity and low physical activity associate with number of hospital admissions and length of hospitalisation in patients with rheumatoid arthritis. Arthritis Res Ther (2011) 0.94
Gingipains from Porphyromonas gingivalis increase the chemotactic and respiratory burst-priming properties of the 77-amino-acid interleukin-8 variant. Infect Immun (2007) 0.94
The magnitude of sudden cardiac death in the young: a death certificate-based review in England and Wales. Europace (2009) 0.94
Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. Rheumatology (Oxford) (2013) 0.93
Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflamm Allergy Drug Targets (2010) 0.92
Proteomic analysis of the anti-inflammatory action of minocycline. Proteomics (2010) 0.92
Randomised, double-blind controlled trial by dose reduction of implanted intrathecal morphine delivery in chronic non-cancer pain. BMJ Open (2013) 0.91
Individualised exercise improves endothelial function in patients with rheumatoid arthritis. Ann Rheum Dis (2013) 0.91
Activation of the neutrophil respiratory burst by plasma from periodontitis patients is mediated by pro-inflammatory cytokines. J Clin Periodontol (2010) 0.91
Subclinical peripheral arterial disease in rheumatoid arthritis. Atherosclerosis (2010) 0.91
The use of proteomics for the assessment of clinical samples in research. Clin Biochem (2004) 0.91
Dyslipidaemia in rheumatological autoimmune diseases. Open Cardiovasc Med J (2011) 0.90
Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation. Clin Rheumatol (2010) 0.89
Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? Rheumatology (Oxford) (2014) 0.89
Nrf2 activation supports cell survival during hypoxia and hypoxia/reoxygenation in cardiomyoblasts; the roles of reactive oxygen and nitrogen species. Redox Biol (2013) 0.88
Arterial hypertension assessed "out-of-office" in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated "white coat" phenomenon. Arthritis Res Ther (2013) 0.87
Oxidative and inflammatory status in Type 2 diabetes patients with periodontitis. J Clin Periodontol (2011) 0.87
Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research. Curr Pharm Des (2012) 0.87
Biologic therapies and systemic bone loss in rheumatoid arthritis. Autoimmun Rev (2013) 0.87